Pfizer-biontech covid-19 vaccine comirnaty® receives full u.s. fda approval for individuals 16 years and older

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) approved the biologics license application (bla) for comirnaty® (covid-19 vaccine, mrna) to prevent covid-19 in individuals 16 years of age and older. comirnaty is the first covid-19 vaccine to be granted approval by the fda. the vaccine has been available in the u.s. under emergency use authorization (eua) since december 11, 2020 (a
BNTX Ratings Summary
BNTX Quant Ranking